240 related articles for article (PubMed ID: 35192684)
1. Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.
Kimura S; Montefiori L; Iacobucci I; Zhao Y; Gao Q; Paietta EM; Haferlach C; Laird AD; Mead PE; Gu Z; Stock W; Litzow M; Rowe JM; Luger SM; Hunger SP; Ryland GL; Schmidt B; Ekert PG; Oshlack A; Grimmond SM; Rehn J; Breen J; Yeung D; White DL; Aldoss I; Jabbour EJ; Pui CH; Meggendorfer M; Walter W; Kern W; Haferlach T; Brady S; Zhang J; Roberts KG; Blombery P; Mullighan CG
Blood; 2022 Jun; 139(24):3519-3531. PubMed ID: 35192684
[TBL] [Abstract][Full Text] [Related]
2. Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Passet M; Kim R; Gachet S; Sigaux F; Chaumeil J; Galland A; Sexton T; Quentin S; Hernandez L; Larcher L; Bergugnat H; Ye T; Karasu N; Caye A; Heizmann B; Duluc I; Chevallier P; Rousselot P; Huguet F; Leguay T; Hunault M; Pflumio F; Freund JN; Lobry C; Lhéritier V; Dombret H; Domon-Dell C; Soulier J; Boissel N; Clappier E
Blood; 2022 Jun; 139(24):3505-3518. PubMed ID: 35316324
[TBL] [Abstract][Full Text] [Related]
3. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
4. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.
Yasuda T; Sanada M; Kawazu M; Kojima S; Tsuzuki S; Ueno H; Iwamoto E; Iijima-Yamashita Y; Yamada T; Kanamori T; Nishimura R; Kuwatsuka Y; Takada S; Tanaka M; Ota S; Dobashi N; Yamazaki E; Hirose A; Murayama T; Sumi M; Sato S; Tange N; Nakamura Y; Katsuoka Y; Sakaida E; Kawamata T; Iida H; Shiraishi Y; Nannya Y; Ogawa S; Taniwaki M; Asou N; Hatta Y; Kiyoi H; Matsumura I; Horibe K; Mano H; Naoe T; Miyazaki Y; Hayakawa F
Blood; 2022 Mar; 139(12):1850-1862. PubMed ID: 34695176
[TBL] [Abstract][Full Text] [Related]
5. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
[TBL] [Abstract][Full Text] [Related]
6. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Hirabayashi S; Ohki K; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yaguchi A; Terada K; Saito Y; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fujimura J; Hino M; Kinoshita A; Kakuda H; Kurosawa H; Kato K; Kajiwara R; Moriwaki K; Morimoto T; Nakamura K; Noguchi Y; Osumi T; Sakashita K; Takita J; Yuza Y; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Fukushima T; Koh K; Manabe A; Ohara A; Kiyokawa N;
Haematologica; 2017 Jan; 102(1):118-129. PubMed ID: 27634205
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Leongamornlert D; Gutiérrez-Abril J; Lee S; Barretta E; Creasey T; Gundem G; Levine MF; Arango-Ossa JE; Liosis K; Medina-Martinez JS; Zuborne Alapi K; Kirkwood AA; Clifton-Hadley L; Patrick P; Jones D; O'Neill L; Butler AP; Harrison CJ; Campbell P; Patel B; Moorman AV; Fielding AK; Papaemmanuil E
Blood Adv; 2023 Aug; 7(15):3862-3873. PubMed ID: 36867579
[TBL] [Abstract][Full Text] [Related]
8. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.
Bastian L; Hartmann AM; Beder T; Hänzelmann S; Kässens J; Bultmann M; Hoeppner MP; Franzenburg S; Wittig M; Franke A; Nagel I; Spielmann M; Reimer N; Busch H; Schwartz S; Steffen B; Viardot A; Döhner K; Kondakci M; Wulf G; Wendelin K; Renzelmann A; Kiani A; Trautmann H; Neumann M; Gökbuget N; Brüggemann M; Baldus CD
Leukemia; 2022 Jun; 36(6):1676-1680. PubMed ID: 35397658
[No Abstract] [Full Text] [Related]
9. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Paietta E; Roberts KG; Wang V; Gu Z; Buck GAN; Pei D; Cheng C; Levine RL; Abdel-Wahab O; Cheng Z; Wu G; Qu C; Shi L; Pounds S; Willman CL; Harvey R; Racevskis J; Barinka J; Zhang Y; Dewald GW; Ketterling RP; Alejos D; Lazarus HM; Luger SM; Foroni L; Patel B; Fielding AK; Melnick A; Marks DI; Moorman AV; Wiernik PH; Rowe JM; Tallman MS; Goldstone AH; Mullighan CG; Litzow MR
Blood; 2021 Sep; 138(11):948-958. PubMed ID: 33895809
[TBL] [Abstract][Full Text] [Related]
10. MEF2D-BCL9 B-Lymphoblastic Leukemia Blast Morphology Does Not Always Mimic Mature B-Cell Leukemia.
Baek HJ; Choi YJ; Kim BR; Lee JH; Shin MG; Kook H
J Pediatr Hematol Oncol; 2021 Apr; 43(3):112-113. PubMed ID: 33235148
[TBL] [Abstract][Full Text] [Related]
11. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Gu Z; Churchman ML; Roberts KG; Moore I; Zhou X; Nakitandwe J; Hagiwara K; Pelletier S; Gingras S; Berns H; Payne-Turner D; Hill A; Iacobucci I; Shi L; Pounds S; Cheng C; Pei D; Qu C; Newman S; Devidas M; Dai Y; Reshmi SC; Gastier-Foster J; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Rambaldi A; Spinelli O; Radich JP; Minden MD; Rowe JM; Luger S; Litzow MR; Tallman MS; Racevskis J; Zhang Y; Bhatia R; Kohlschmidt J; Mrózek K; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Evans WE; Jeha S; Pui CH; Yang J; Paietta E; Downing JR; Relling MV; Zhang J; Loh ML; Hunger SP; Mullighan CG
Nat Genet; 2019 Feb; 51(2):296-307. PubMed ID: 30643249
[TBL] [Abstract][Full Text] [Related]
12. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Griffith M; Griffith OL; Krysiak K; Skidmore ZL; Christopher MJ; Klco JM; Ramu A; Lamprecht TL; Wagner AH; Campbell KM; Lesurf R; Hundal J; Zhang J; Spies NC; Ainscough BJ; Larson DE; Heath SE; Fronick C; O'Laughlin S; Fulton RS; Magrini V; McGrath S; Smith SM; Miller CA; Maher CA; Payton JE; Walker JR; Eldred JM; Walter MJ; Link DC; Graubert TA; Westervelt P; Kulkarni S; DiPersio JF; Mardis ER; Wilson RK; Ley TJ
Exp Hematol; 2016 Jul; 44(7):603-13. PubMed ID: 27181063
[TBL] [Abstract][Full Text] [Related]
14. 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
Yang M; Safavi S; Woodward EL; Duployez N; Olsson-Arvidsson L; Ungerbäck J; Sigvardsson M; Zaliova M; Zuna J; Fioretos T; Johansson B; Nord KH; Paulsson K
Blood; 2020 Aug; 136(8):946-956. PubMed ID: 32384149
[TBL] [Abstract][Full Text] [Related]
15. Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.
Shago M; Abla O; Hitzler J; Weitzman S; Abdelhaleem M
Pediatr Blood Cancer; 2016 Nov; 63(11):1915-21. PubMed ID: 27392123
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
[TBL] [Abstract][Full Text] [Related]
17. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract][Full Text] [Related]
18. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia.
Tokunaga K; Yamaguchi S; Iwanaga E; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N
Eur J Haematol; 2013 Sep; 91(3):201-208. PubMed ID: 23751147
[TBL] [Abstract][Full Text] [Related]
19. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
[TBL] [Abstract][Full Text] [Related]
20. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
Mullighan CG
Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
